Diagnosis and Screening of Neurological Disorders

Early diagnosis and proper screening of neurological disorders is the key for better prognosis and cure. Investigating the damage caused to the nervous system is extremely complicated and complex. Most of the similar symptoms happen in different disorders. There are many disorders which doesn't have definitive causes, markers, or tests, that makes a diagnosis even harder.

To confirm a neurologic condition such as brain injury, tumors, hydrocephalus, aneurysm, epilepsy or stroke, a range of neurologic tests are performed.

Sub-track

  • CT scan
  • Electroencephalogram (EEG
  • MRI
  • nerve conduction velocity
  • electromyography
  • Positron emission tomography
  • Arteriogram
  • Spinal tap
  • Neurosonography
  • Ultrasound

Market Analysis: Several neurological disorders, such as Multiple Sclerosis, Alzheimer's disease (AD), and Parkinson's disease, are diagnosed with neurological disorder diagnostic instruments (PD). 
Furthermore, the recent rise in the prevalence of neurological disorders is expected to drive the global neurological disease diagnostic market. 
The neurodiagnostics market is estimated to grow at a CAGR of 7.3 percent from USD 5.9 billion in 2019 to USD 8.4 billion in 2024.
The growing prevalence of neurological disorders and diseases, technological advancements, growing patient emphasis on effective and early disease diagnosis, the growing number of diagnostic centres and hospitals, and the use of biomarker profiling for disease diagnostics are all expected to drive demand for neurodiagnostics products. The global neurological biomarkers market was valued at USD 6.1 billion in 2020, with a compound annual growth rate (CAGR) of 12.9 percent predicted from 2020 to 2028. Furthermore, technological improvements are fueling market expansion by increasing the requirement for early identification of neurological illnesses.
 

ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons Disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case Studies and Clinical Trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders Behavioral Neurology Computational Neuroscience Neurogenetics Spinal Neurosurgery Pediatric Neurosurgery Stereotactic and Functional Neurosurgery Neurovascular Surgery Intraoperative Neurophysiology Peripheral Nerve Surgery Robotics in Neurosurgery Latest advancement in Brain Surgery Skull Base Surgery Trauma and Critical Care Child Psychology Social Cognitive Neuroscience Neurophysics Neuroradiology Neurorobotics Advanced Imaging Techniques Personalized Medicine Neuroinformatics Gene Therapy Neural Interface and Brain-Computer Interface BCI Neurorehabilitation Regenerative Medicine and Stem Cell Therapy Telemedicine in Neurology Nano-Neuroscience Neurosurgical Innovations Neuroethics Precision Psychiatry Neuromodulation and New Therapeutic Approaches Microbiome and Neurological Health Neurological Implications of COVID-19

Tags
Neurology Conferences Europe Neurophysiology Conferences Seizures Conferences Neurological Disorders Conferences Brain Cancer Conferences Neuroscience Conferences 2024 Dubai Muscular Dystrophy Conferences Psychology Conferences Neurology Conferences 2024 Europe Headache Conferences Cerebrovascular Disease Conferences Neurology Conferences 2024 USA Neurology Conferences 2024 USA Neurology Conferences Neurology Conferences 2024 UK

+1-778-244-7702